Diagnosis and Monitoring Hepatitis C InfectionFall 1999 A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! Learning if you have been exposed to HEP C is not so difficult, finding out if you are infected, and if so, what is going on in your body as a result of the infection can be. Ultimately you will need a number of tests to give you this important information. To learn whether or not you have been exposed to HEP C, start with a HEP C antibody test, also known as HEP C ELISA, which looks for antibodies that your immune system produces after you are exposed. In general most individuals that are exposed to HEP C will produce antibodies eventually, unless they are severely immunocompromised. The test can be tricky. False positives show up in about one out of every four cases. If your test is negative, and you know that you are at risk, follow it up with a more specific test called a qualitative HEP C PCR to make sure (see below). Viral Load Testing (PCR)
The second type of PCR test or viral load test is quantitative, which means it tells you how much virus is in a particular sample of blood. Most people with HEP C have viral loads anywhere between 100,000 and ten million, and sometimes higher. There's no comparison between HEP C viral loads and those for HIV. Whereas a viral load of one or two million is considered very high in HIV, the same result in HEP C isn't necessarily considered high. There is almost no information yet about how specific HEP C viral load levels relate to the likelihood of current or future liver damage. So, as with liver enzymes, don't make any decisions based solely on viral load results. Monitoring Disease ProgressionOnce you are sure that you are chronically infected with HEP C, you will want to know what condition your liver is in so that you can make important treatment decisions. As your liver goes about its business, it secretes enzymes into your blood which are measured each time you get your blood work. If you're HEP C-positive, most doctors will simply monitor your liver enzymes (ALT, AST) every six months. It's a good idea to get a baseline reading, however your enzyme numbers can be affected by so many variants that they're only worthwhile for comparison purposes over time. If you're taking anti-HIV medications for example, or any medications for that matter, your liver enzymes may be on the high end as your liver works overtime to metabolize (break down) the medications. And if your liver is in really bad shape, your enzyme levels may be normal or low because your liver is too worn out to make the enzymes. Alcohol and street drugs can also significantly damage the liver, resulting in increased liver function tests. So, overall, monitoring liver enzymes isn't a useful indicator of liver damage, but can be used with other tests to tell you what state you liver is in. Your doctor may also want to get a quantitative HEP C PCR (viral load) over time for comparison which tells you how much hepatitis C virus you have in your blood. Liver BiopsyYou can monitor your symptoms, liver enzymes and HEP C viral load, but without having a liver biopsy, you really can't tell how your liver is doing. If you're feeling just fine, you're unlikely to jump at the chance to go through an invasive, uncomfortable, if not downright painful procedure. A liver biopsy is currently the most accurate way to measure the progression of liver damage. This is an outpatient procedure that just takes a few minutes while you're awake. A needle is inserted through your abdomen, just below your right ribs, into your liver, and a small tissue sample is taken out and examined under a microscope by a doctor called a pathologist. Because the sample is only from one part of the liver it can't tell you what's going on in other parts of your liver, but it is a useful diagnostic tool to measure the degree of inflammation, fibrosis and cirrhosis in that sample. It's particularly important and at present, necessary if you're considering treatment. Liver biopsy can be repeated to assess disease progression over time. As with any surgical procedure, preparation is required and there are risks involved. It is important to understand everything your doctor says to you about a biopsy before you undergo one. Genotypic TestsOf the three main HEP C genotypes (1, 2 and 3), genotype 1 is the most common in the United States, accounting for about 70% of US infections. It is also, unfortunately, the genotype least likely to respond to the treatments currently available. A genotype describes the basic genetic make-up of your particular strain of virus. Learning your genotype may give you some statistical information about how likely you are to benefit from treatment, but at this time it's still primarily a research tool. The language used by many HEP C researchers is curious and inaccurate. When you look through the literature at studies and articles or attend research presentations, terms such as "cure," "eradication," and "PCR-negative" repeatedly come up. These words can be misleading and confusing. However, largely due to PLWAs' influence on the language of HIV and the many researchers and doctors who understand the importance of using language that reflects what's truly going on, the language of HEP C is slowly evolving. "PCR-negative" is now often replaced by "undetectable viral load"; "eradication" is most often used only when talking about that 15% or so of folks who spontaneously clear the virus from their systems after initial infection; and that loaded word "cure" appears less often now, when what is really meant is a sustained undetectable viral load.
A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information! This article was provided by AIDS Community Research Initiative of America. It is a part of the publication CRIA Update. Visit ACRIA's website to find out more about their activities, publications and services.
|
|
||||||||||||||||||||||||||||||||||||